InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: dia76ca post# 73490

Monday, 01/02/2012 5:53:40 PM

Monday, January 02, 2012 5:53:40 PM

Post# of 346050
dia76ca, agree with your insightful post...while watching the very green Oregon Ducks struggle against Wisconsin boxcars and trucks. One huge problem is the need for a paradigm shift in cancer treatment, a need that has been present for decades, but a catch-22 we can't seem to extract ourselves from, and that is use of cytotoxic, immunosuppressive agents in the presence of immunocompromised patients, by definition. My post about Ribavirin was to point out some of the apparent futility of wanting positive results from immunostimulatroy agents like Bavituximab being used in combination with immunosuppressants. If Bavituximab stimulates what's left of the body's immune system to produce specialized scavenger cells, how that that synch with its use with a compound like Ribavirin that is known to inhibit new cell and specialized protein production? I know you were shuckin', but I don't look for Bavi to be packing Ribavirin OR intereron ANYwhere.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News